FNM S.p.A.
FNM S.p.A. engages in the railway mobility business in Italy. It operates through the Freeways, Railway infrastructure Energy, RO.S.CO., and Mobility and Services segments. The company is involved in the design, construction, and management of motorways and the ring roads, terminal management activity, the renewable energy business, the development of new plants, the rental of rolling stock of ro… Read more
FNM S.p.A. (0EHB) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, FNM S.p.A. (0EHB) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
FNM S.p.A. - Net Assets Trend (None–None)
This chart illustrates how FNM S.p.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for FNM S.p.A. (None–None)
The table below shows the annual net assets of FNM S.p.A. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to FNM S.p.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
FNM S.p.A. Competitors by Market Cap
The table below lists competitors of FNM S.p.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Phenixfin Corporation
NASDAQ:PFX
|
$61.94 Million |
|
NewMed Energy - Limited Partnership
TA:NWMD
|
$62.00 Million |
|
Magnate Technology Co Ltd
TWO:4541
|
$62.02 Million |
|
Liquidmetal Technologies Inc
OTCQB:LQMT
|
$62.07 Million |
|
Clover Leaf Capital Corp
PINK:CLOE
|
$61.91 Million |
|
China Ecotek Corp
TW:1535
|
$61.88 Million |
|
MediciNova Inc
NASDAQ:MNOV
|
$61.88 Million |
|
Easy Field
TWO:6425
|
$61.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FNM S.p.A.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares FNM S.p.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently FNM S.p.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares FNM S.p.A.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FNM S.p.A. (0EHB) | €- | N/A | N/A | $61.92 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |